Mochi Health vs Henry Meds: Two Compounded GLP-1 Providers Under Active Litigation
Mochi Health and Henry Meds are the two most-litigated providers in our compounded-GLP-1 cohort, but the failure modes are different. Mochi has the larger consumer review sample (Trustpilot 4.4/5 across 15,600+ reviews, no fraud notice) but a Washington State Notice of Immediate Jeopardy on its affiliated compounding pharmacy plus two active manufacturer lawsuits. Henry Meds has the cohort's worst BBB rating (F with 25 unanswered complaints), a Trustpilot suspected-fraudulent-review notice on its profile page, and an active Eli Lilly lawsuit. Neither is the right answer for most readers; this comparison is for users specifically choosing between them.
Mochi Health
2.8Flat-rate compounded GLP-1 with a vertically-integrated pharmacy under active state and federal scrutiny
Henry Meds
2.7Cohort-cheapest compounded GLP-1, with the cohort-worst trust signals
Reviewed by Designing Longevity Editorial·Last verified May 1, 2026
Bottom line
Mochi over Henry Meds in most criteria, but neither is the right default. Mochi has stronger consumer-service signals (clean Trustpilot vs Henry Meds's fraud notice; better cancellation flow), the more innovative pricing model (dose-independent flat rate vs Henry Meds's hidden secondary subscription), and board-certified obesity-medicine physicians. Henry Meds has a single manufacturer lawsuit instead of two. For readers comparing these two specifically, the answer is Mochi if you've read the WA State enforcement record on Aequita and decided you're comfortable; otherwise look at TrimRx or Eden, the cleaner alternatives.
Side-by-side at a glance
Who wins for each use case
We pick a winner per criterion and explain the reasoning. Skip to whichever rows match how you'd actually use the platform.
BBB rating and complaint posture
Winner: Mochi HealthHenry Meds is NOT BBB-accredited and carries an F letter grade with 25 unanswered complaints out of 192 over three years. Mochi is also NOT BBB-accredited but has no F-grade complaint volume; complaints concentrate on cancellation and refund, and Mochi has been responsive to most BBB complaints per public records. Mochi wins this row clearly even though both are imperfect.
Trustpilot signal credibility
Winner: Mochi HealthHenry Meds shows 4.5/5 across 12,300+ reviews but the page carries Trustpilot's suspected-fraudulent-review notice. Mochi shows 4.4/5 across 15,600+ reviews with no fraud notice. Mochi's slightly lower headline rating is meaningfully more credible than Henry Meds's higher but flagged sample. We weight the fraud-notice flag more than the average; Mochi wins this row.
Pharmacy-quality regulatory record
Winner: Henry MedsHenry Meds has no FDA warning letter or state pharmacy enforcement on record. Mochi's affiliated Aequita Pharmacy received a Washington State Notice of Immediate Jeopardy after substantiated whistleblower allegations. The lawsuit against Henry Meds is marketing-claim litigation; Mochi's pharmacy enforcement is structurally more severe because it's about product-quality operations. Henry Meds wins this row on the absence of comparable state pharmacy action, even though both have other counterweights.
Manufacturer lawsuit posture
Winner: Henry MedsHenry Meds has one active federal lawsuit (Eli Lilly v. Adonis Health, Inc., 4:25-cv-03536). Mochi has two: Eli Lilly v. Mochi Health (April 2025 marketing) and Novo Nordisk v. Mochi Health Corp. 5:25-cv-06563 (August 2025 marketing plus corporate-practice-of-medicine). Two lawsuits is more than one, and Novo's corporate-practice-of-medicine claim is structurally broader.
Cancellation friction
Winner: Mochi HealthHenry Meds requires a phone call to cancel (no in-app self-serve flow); BBB complaints document a pattern of unanswered calls and continued billing after attempted cancellation. Mochi has BBB complaints on cancellation as well but the operational pattern is not as severe. Mochi wins this row by a clear margin.
Pricing transparency
Winner: Mochi HealthMochi's flat-rate $99/mo semaglutide and $199/mo tirzepatide at every dose tier is straightforward. Henry Meds's headline pricing ($99/mo oral semaglutide is comparable to Mochi's flat rate) is undermined by the BBB-documented secondary $49/mo subscription buried in the terms of service. Mochi's pricing is genuinely transparent in a way Henry Meds's is not.
Physician credentials
Winner: Mochi HealthMochi's prescribing care model uses board-certified obesity-medicine physicians, a real differentiator named consistently in user reviews. Henry Meds prescribes through licensed clinicians but does not market comparable specialty credentials. Mochi wins this row on the clinical-side care model.
Oral tirzepatide tablet availability
Winner: Henry MedsHenry Meds offers oral tirzepatide tablets at $349/mo or $234/mo on annual prepay, a relatively rare product line. Mochi focuses on injectable formulations. If you specifically want oral tirzepatide, Henry Meds is one of the few options that carries it.
Rubric scores side-by-side
Same six dimensions we use on every provider profile, weighted to a single 0-5 score. Click through to either profile for the verification details behind each row.
Licensure 20% weight
Accreditation 20% weight
Transparency 20% weight
Product quality 15% weight
Pricing 15% weight
Customer service 10% weight
Pricing in plain terms
Mochi: $79/mo membership + $99/mo flat semaglutide or $199/mo flat tirzepatide at every dose ($178-$278/mo all-in). Henry Meds: $99/mo oral semaglutide, $149-$179/mo injectable semaglutide, $349/mo oral tirzepatide tablets, $449/mo injectable tirzepatide, plus the BBB-flagged secondary $49/mo subscription. Headline pricing is similar but Mochi's flat-rate dose-independent structure is materially different from Henry Meds's variable-dose-plus-hidden-subscription structure. For most readers, neither is the right default; route to TrimRx (cohort top pick) or Eden (vertically integrated without comparable enforcement) instead.
Read the full profiles
This comparison summarizes the head-to-head call. The full provider profiles include verification items, regulatory history, public-review aggregation, and the signup walkthrough.